Investor interest in telehealth surged during the Covid-19 pandemic. While the healthcare industry’s widespread adoption of telehealth was driven by necessity due to social distancing practices, such expansion would not have been possible without federal and state governments waiving many legal and regulatory requirements that had previously hindered such telehealth growth. Many of these waivers were temporary and tied to public health emergencies (“PHEs”) which either have already or will soon expire.
In turn, the volume of telehealth investments has already begun to decline. In fact, 2023 is projected to be the lowest telehealth funding year since 2019. This begs the question – is the slowing telehealth investment due to the tightening credit markets and an expected economic downturn, or should the telehealth industry expect the trend of decreased investor interest to continue in a post-PHE world?
A review of federal, state, and private payer activity indicates interest in telehealth remains strong. As such, as the credit market stabilizes and fears of a recessions begin to recede, investor interest in telehealth is expected to return, reports MedCity News. Read more.
